Trial Profile
PHASE II STUDY OF CLOFARABINE IN COMBINATION WITH CYTARABINE AND LIPOSOMAL DOXORUBICIN IN CHILDREN WITH EITHER LYMPHOBLASTIC OR MYELOID RELAPSE OR REFRACTORY ACUTE LEUKEMIA AND IN CHILDREN WITH SECONDARY ACUTE MYELOID LEUKEMIA STUDIO DI FASE II SULL'UTILIZZO DI CLOFARABINA IN COMBINAZIONE CON CITARABINA E DOXORUBICINA LIPOSOMIALE IN PAZIENTI PEDIATRICI CON DIAGNOSI DI LEUCEMIA LINFOBLASTICA ACUTA E LEUCEMIA MIELOIDE ACUTA IN RECIDIVA O REFRATTARIA O DI LEUCEMIA MIELOIDE ACUTA SECONDARIA
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Dec 2022
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Cytarabine; Doxorubicin liposomal
- Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- Acronyms CLA-MYOCET
- 19 Dec 2022 Status changed from recruiting to completed.
- 03 Mar 2014 New trial record